Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 189

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Redefining fatty liver disease: an international patient perspective

Shiha, Gamal, Korenjak, Marko, Eskridge, Wayne, Casanovas, Teresa, Velez-Moller, Patricia, Högström, Sari, Richardson, Ben, Munoz, Christopher, Sigurðardóttir, Sólveig, Coulibaly, Alioune, Milan, Miskovikj, Bautista, Fabiana, Leung, Nancy Wai Yee, Mooney, Vicki, Obekpa, Solomon, Bech, Eva, Polavarapu, Naveen, Hamed, Abd Elkhalek, Radiani, Temur, Purwanto, Edhie, Bright, Bisi, Ali, Mohammad, Dovia, Cecil Kwaku, McColaugh, Lone, Koulla, Yiannoula, Dufour, Jean-François, Soliman, Reham, Eslam, Mohammed · 2021 · The Lancet Gastroenterology & Hepatology

Abstract

Despite its increased recognition as a major health threat, fatty liver disease associated with metabolic dysfunction remains largely underdiagnosed and undertreated. An international consensus panel has called for the disease to be renamed from non-alcoholic fatty liver disease (NAFLD) to metabolic-associated fatty liver disease (MAFLD) and has suggested how the disease should be diagnosed. This Viewpoint explores the call from the perspective of patient advocacy groups. Patients are well aware of the negative consequences of the NAFLD acronym. This advocacy group enthusiastically endorses the call to reframe the disease, which we believe will ultimately have a positive effect on patient care and quality of life and, through this effect, will reduce the burden on health-care systems. For patients, policy makers, health planners, donors, and non-hepatologists, the new acronym MAFLD is clear, squarely placing the disease as a manifestation of metabolic dysfunction and improving understanding at a public health and patient level. The authors from representative patient groups are supportive of this change, particularly as the new acronym is meaningful to all citizens as well as governments and policy makers, and, above all, is devoid of any stigma.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2468-1253(20)30294-6

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 189

Metadata

Authors
Shiha, G., Korenjak, M., Eskridge, W., Casanovas, T., Velez-Moller, P., Högström, S., Richardson, B., Munoz, C., Sigurðardóttir, S., Coulibaly, A., Milan, M., Bautista, F., Leung, N. W. Y., Mooney, V., Obekpa, S., Bech, E., Polavarapu, N., Hamed, A. E., Radiani, T., Purwanto, E., Bright, B., Ali, M., Dovia, C. K., McColaugh, L., Koulla, Y., Dufour, J.-F., Soliman, R., & Eslam, M.
Venue
The Lancet Gastroenterology & Hepatology
Publisher
Elsevier BV
Published
2021-01
Volume
6
Issue
1
Pages
73-79
ISSN
  • 2468-1156 (ISSN-L)
  • 2468-1253
OpenAlex
W3091848476
Cited by
189
References
6
FWCI
19.97
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Redefining fatty liver disease: an international patient perspective. https://app.cochat.ai/papers/10.1016/s2468-1253(20)30294-6
The paper
Shiha, G., Korenjak, M., Eskridge, W., Casanovas, T., Velez-Moller, P., Högström, S., Richardson, B., Munoz, C., Sigurðardóttir, S., Coulibaly, A., Milan, M., Bautista, F., Leung, N. W. Y., Mooney, V., Obekpa, S., Bech, E., Polavarapu, N., Hamed, A. E., Radiani, T., . . . Eslam, M. (2021). Redefining fatty liver disease: an international patient perspective. The Lancet Gastroenterology & Hepatology. https://doi.org/10.1016/s2468-1253(20)30294-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.